These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6818272

  • 1. Antibacterial activity of cephamandole--a new antibiotic.
    Goyal P, Bhatia R, Baveja UK, Agarwal DS.
    J Commun Dis; 1982 Jun; 14(2):130-3. PubMed ID: 6818272
    [No Abstract] [Full Text] [Related]

  • 2. Activity of cephamandole against some gram-negative bacilli and staphylococci.
    Dzierzanowska D, Jakubicz P, Niedźwiecka M, Borowski J.
    Arch Immunol Ther Exp (Warsz); 1980 Jun; 28(3):389-91. PubMed ID: 6969585
    [Abstract] [Full Text] [Related]

  • 3. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A, Durosoir JL, Saliou P.
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [Abstract] [Full Text] [Related]

  • 4. Antibacterial activity of five cephalosporins.
    Mutton KJ, Harkness JL.
    Pathology; 1981 Jan; 13(1):73-7. PubMed ID: 6784093
    [Abstract] [Full Text] [Related]

  • 5. Investigation into the antibacterial activity in vitro of cement-antibiotic mixtures.
    Greco F, Rossi A, De Palma L, Spagnolo N.
    Ital J Orthop Traumatol; 1981 Apr; 7(1):103-13. PubMed ID: 6799427
    [Abstract] [Full Text] [Related]

  • 6. [Antibacterial activity of sodium cefuroxim as compared to cephalosporin].
    Borrata S, Gabbrielli G.
    G Ital Chemioter; 1979 Apr; 26(1-2):385-6. PubMed ID: 122079
    [No Abstract] [Full Text] [Related]

  • 7. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN, Fuchs PC, Barry AL, Gavan TL, Gerlach EH, Sommers HM.
    Clin Ther; 1980 Apr; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Activity of cefamandole against enterobacteria resistant to cephalosporins (author's transl)].
    Kazmierczak A, Gailliard MC, Portier H, Siebor E, Labia R.
    Nouv Presse Med; 1979 Oct 15; 8(39):3157-60. PubMed ID: 261332
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H, Kubota T, Itani H, Ishitobi H, Miwa H, Nishitani Y.
    Bioorg Med Chem; 2004 Aug 01; 12(15):4211-9. PubMed ID: 15246097
    [Abstract] [Full Text] [Related]

  • 17. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV, Sanders CC, Sanders W.
    J Antibiot (Tokyo); 1978 Apr 01; 31(4):363-72. PubMed ID: 306989
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.